Company: IDM Pharma, Inc.

Jason Gerlach, Principal & Managing Director, Sunrise Capital Partners LLC says that traditional diversification strategies no longer work b...

Investors have made big bets on drugs like Pfizer's Lipitor for cholesterol, Glaxo's Advair for Asthma, and many more. CNBC's Seema Mody rep...

The market for diabetes is a profitable one, says Mad Money host Jim Cramer.

Kris Jenner, Row Price Health Sciences Fund, discusses opportunities in health care. "Big pharma is improving," he tells CNBC's Fast Money.

Jared Bernstein, Center on Budget and Policy Priorities senior fellow and CNBC's Rick Santelli, debate over the government's role in JPMorga...

Bristol-Myers' top selling blood thinner "Plavix" is going generic, reports CNBC's Seema Mody. Matt Cheslock, Virtu Financial, weighs in on ...

POPULAR TAGS